SCHEER PARTNERS REPRESENTS VACCINE MAKER NOVAVAX IN 74,209-SQUARE-FOOT GAITHERSBURG LEASE
Gaithersburg, MD – In a deal negotiated by Scheer Partners executives, Novavax Inc., a clinical-stage biopharmaceutical company that is developing novel vaccines to address a broad range
December 8, 2022